US Stock MarketDetailed Quotes
AADI Aadi Biosciences
- 3.390
- +1.070+46.12%
Close Dec 20 16:00 ET
- 3.030
- -0.360-10.62%
Post 19:58 ET
83.55MMarket Cap-1.49P/E (TTM)
3.600High2.070Low9.21MVolume2.520Open2.320Pre Close26.23MTurnover66.13%Turnover RatioLossP/E (Static)24.65MShares3.60052wk High1.21P/B47.21MFloat Cap1.21052wk Low--Dividend TTM13.93MShs Float65.250Historical High--Div YieldTTM65.95%Amplitude1.210Historical Low2.848Avg Price1Lot Size
Aadi Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -31.26%-15.69M | 45.36%-9.16M | 7.78%-19.65M | -20.19%-59.66M | 14.73%-9.64M | -45.83%-11.95M | -56.32%-16.76M | -9.76%-21.31M | -121.38%-49.64M | 9.00%-11.31M |
| Net income from continuing operations | 23.04%-12.55M | 18.85%-14.58M | -20.14%-18.29M | -8.68%-65.77M | -16.93%-16.27M | -12.63%-16.3M | 1.63%-17.97M | -9.86%-15.22M | 45.03%-60.51M | 12.99%-13.91M |
| Depreciation and amortization | 6.82%47K | 13.95%49K | 31.58%50K | 6.29%169K | -4.35%44K | 266.67%44K | 59.26%43K | -48.65%38K | 51.43%159K | -36.11%46K |
| Other non cash items | -17.39%95K | 0.00%115K | -0.57%173K | 35.86%519K | 2.68%115K | 5,850.00%115K | -22.30%115K | 40.32%174K | -54.31%382K | -5.88%112K |
| Change In working capital | -419.53%-5.53M | 347.14%2.81M | 39.35%-4.75M | -87.03%-3.4M | 499.22%3.84M | -52.72%1.73M | -180.35%-1.14M | -4.01%-7.84M | -114.86%-1.82M | -67.76%641K |
| -Change in receivables | 69.62%-620K | -152.25%-987K | 114.99%555K | -94.74%-3.63M | -42.61%229K | -930.81%-2.04M | 192.87%1.89M | -36.74%-3.7M | -113.16%-1.86M | --399K |
| -Change in inventory | 95.65%630K | -127.93%-162K | 125.23%490K | -75.44%-3.27M | -97.43%-2.23M | 4,700.00%322K | 210.48%580K | -861.39%-1.94M | ---1.86M | ---1.13M |
| -Change in prepaid assets | -89.65%179K | -0.87%1.47M | 248.44%953K | 346.27%3.6M | 794.78%1.03M | 264.04%1.73M | 2,603.64%1.49M | -10.88%-642K | 32.46%-1.46M | 107.01%115K |
| -Change in payables and accrued expense | -453.98%-6.1M | 148.73%2.5M | -338.08%-6.76M | -104.10%-132K | 269.53%4.82M | -65.73%1.72M | -603.54%-5.13M | 62.61%-1.54M | -61.16%3.22M | -62.01%1.3M |
| -Change in other current assets | -7.32%114K | -27.67%115K | 18.97%138K | 18.54%518K | 66.67%120K | 51.85%123K | 0.00%159K | -7.20%116K | -9.15%437K | 41.18%72K |
| -Change in other current liabilities | 312.00%265K | -1.59%-128K | -1.61%-126K | -72.51%-502K | -4.96%-127K | 33.86%-125K | -300.00%-126K | -181.82%-124K | 96.58%-291K | -182.31%-121K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -31.26%-15.69M | 45.36%-9.16M | 7.78%-19.65M | -20.19%-59.66M | 14.73%-9.64M | -45.83%-11.95M | -56.32%-16.76M | -9.76%-21.31M | -121.38%-49.64M | 9.00%-11.31M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -59.86%5.09M | -107.06%-3.57M | -35.36%10.56M | 162.61%83.21M | 104.32%3.65M | 126.26%12.67M | 21,079.67%50.56M | 71,095.65%16.33M | -628.31%-132.89M | -183,332.61%-84.38M |
| Net PPE purchase and sale | 82.88%-188K | 21.48%-541K | 46.02%-739K | -794.59%-3.97M | -946.15%-816K | -976.47%-1.1M | -185.89%-689K | -5,852.17%-1.37M | -865.22%-444K | -69.57%-78K |
| Net investment purchase and sale | -61.69%5.27M | -105.91%-3.03M | -36.18%11.29M | 165.82%87.18M | 105.30%4.47M | 128.59%13.77M | --51.25M | --17.7M | ---132.44M | ---84.3M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -59.86%5.09M | -107.06%-3.57M | -35.36%10.56M | 162.61%83.21M | 104.32%3.65M | 126.26%12.67M | 21,079.67%50.56M | 71,095.65%16.33M | -628.31%-132.89M | -183,332.61%-84.38M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -72.20%87K | -225.00%-10K | -99.55%326K | 174.77%80K | -100.10%-75K | 459.77%313K | -97.32%8K | -48.79%72.62M | -221.59%-107K |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -53.23%72.5M | --0 |
| Proceeds from stock option exercised by employees | --0 | -74.03%94K | --0 | -37.61%486K | -65.35%114K | -87.50%2K | 166.18%362K | -97.32%8K | -6.48%779K | 273.86%329K |
| Net other financing activities | --0 | ---7K | ---10K | 75.72%-160K | 92.20%-34K | ---77K | ---- | ---- | 93.15%-659K | ---436K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -72.20%87K | -225.00%-10K | -99.55%326K | 174.77%80K | -100.10%-75K | 459.77%313K | -97.32%8K | -48.79%72.62M | -221.59%-107K |
| Net cash flow | ||||||||||
| Beginning cash position | -39.61%41.2M | 57.85%53.84M | 61.07%62.95M | -73.77%39.08M | -48.94%68.87M | -42.57%68.23M | -73.73%34.11M | -73.77%39.08M | 3,244.31%148.99M | -16.42%134.88M |
| Current changes in cash | -1,753.98%-10.6M | -137.05%-12.64M | -83.15%-9.11M | 121.72%23.87M | 93.83%-5.92M | -96.01%641K | 408.80%34.12M | 74.02%-4.97M | -176.04%-109.91M | -673.42%-95.8M |
| End cash Position | -55.57%30.6M | -39.61%41.2M | 57.85%53.84M | 61.07%62.95M | 61.07%62.95M | -48.94%68.87M | -42.57%68.23M | -73.73%34.11M | -73.77%39.08M | -73.77%39.08M |
| Free cash flow | -21.66%-15.88M | 44.41%-9.7M | 10.08%-20.39M | -27.06%-63.64M | 8.15%-10.46M | -57.27%-13.05M | -59.17%-17.45M | -16.67%-22.68M | -122.90%-50.08M | 8.71%-11.39M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
